dc.creator | Neves, Juliana Kelle de Andrade Lemoine | |
dc.creator | Sarinho, S. | |
dc.creator | Melo, C. M. L. de | |
dc.creator | Pereira, V. R. A. | |
dc.creator | Lima, M. C. A. de | |
dc.creator | Pitta, I. R. | |
dc.creator | Albuquerque, M. C. P. A. | |
dc.creator | Galdino, S. L. | |
dc.date | 2018-09-13T12:27:26Z | |
dc.date | 2018-09-13T12:27:26Z | |
dc.date | 2011 | |
dc.date.accessioned | 2023-09-26T21:14:46Z | |
dc.date.available | 2023-09-26T21:14:46Z | |
dc.identifier | JKAL, N. et al. Immunological studies and in vitro schistosomicide action of new imidazolidine derivatives. Journal of Venomous Animals and Toxins including Tropical Diseases, v. 17, n. 3, p. 277–286, 2011. | |
dc.identifier | 1678-9199 | |
dc.identifier | https://www.arca.fiocruz.br/handle/icict/28721 | |
dc.identifier | 10.1590/S1678-91992011000300007 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/8871432 | |
dc.description | Fundação Federal de Pesquisa e Desenvolvimento (FINEP), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) e Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) | |
dc.description | Schistosomiasis is a major public health problem with 207 million people infected and more than 779 million at risk. The drug of choice for treating schistosomiasis is praziquantel (PZQ); however, it is inefficient against immature forms of schistosomes. The aim of this study was to test new imidazolidine derivatives LPSF/PT09 and LPSF/PT10 against adult Schistosoma mansoni worms. IC50, cytotoxicity, immune response and cell viability assays were also available for these imidazolidines. Different concentrations of imidazolidine, from 32 to 320 ¼M, promoted motor abnormalities in breeding and unpaired worms, and death in 24 hours at higher concentrations. Although LPSF/PT09 and LPSF/PT10 did not affect IFN-³ and IL-10 production, they induced nitric oxide production and showed a similar behavior to praziquantel on cell death test. Thus, these new imidazolidine derivatives should undergo further study to develop schistosomiasis drugs. | |
dc.format | application/pdf | |
dc.language | eng | |
dc.rights | open access | |
dc.subject | Schistosoma mansoni | |
dc.subject | In vitro | |
dc.subject | Imidazolidina | |
dc.subject | Schistosoma mansoni | |
dc.subject | In vitro | |
dc.subject | Imidazolidines | |
dc.subject | Schistosoma mansoni / imunologia | |
dc.subject | Schistosoma mansoni / epidemiologia | |
dc.subject | Brasil / epidemiologia | |
dc.subject | Humanos | |
dc.subject | Schistosoma mansoni / efeitos dos fármacos | |
dc.subject | Citotoxicidade Imunológica | |
dc.subject | Testes Imunológicos de Citotoxicidade | |
dc.subject | Técnicas In Vitro | |
dc.title | Immunological studies and in vitro schistosomicide action of new imidazolidine derivatives | |
dc.type | Article | |